| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NextCure, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 117,375 | 31 Jan 2025 | Direct | ||
| NextCure, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 93,900 | 29 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | 31 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 03 Feb 2025, 18:22 |
| NXTC | NextCure, Inc. | 29 Mar 2024 | 1 | $0 | 4 | Chief Financial Officer | 02 Apr 2024, 16:38 |
| NXTC | NextCure, Inc. | 31 Jan 2024 | 1 | $0 | 4 | Chief Financial Officer | 01 Feb 2024, 16:43 |
| NXTC | NextCure, Inc. | 28 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 01 Mar 2023, 17:01 |
| NXTC | NextCure, Inc. | 31 Jan 2022 | 1 | $0 | 4 | Chief Financial Officer | 02 Feb 2022, 15:16 |